M&A Deal Summary

Becton Dickinson Acquires Cato Software Solutions

On March 12, 2013, Becton Dickinson acquired software company Cato Software Solutions

Acquisition Highlights
  • This is Becton Dickinson’s 1st transaction in the Software sector.
  • This is Becton Dickinson’s 1st transaction in Austria.

M&A Deal Summary

Date 2013-03-12
Target Cato Software Solutions
Sector Software
Buyer(s) Becton Dickinson
Deal Type Add-on Acquisition

Target

Cato Software Solutions

Vienna, Austria
Cato Software Solutions is the manufacturer of cato® and chemocato® software, a suite of comprehensive medication safety solutions for pharmacy intravenous medication preparation, physician therapy planning and nurse bedside documentation. Cato provides an automated system that creates and shares data to help reduce human error, standardize practice, streamline workflow and increase efficiency from medication preparation to delivery, in both pharmacy and clinical drug delivery settings.

Search 215,029 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Becton Dickinson

Franklin Lake, New Jersey, United States

Category Company
Founded 1897
Sector Medical Products
Employees70,000
Revenue 20.2B USD (2024)
DESCRIPTION

Becton Dickinson is a global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. Becton Dickinson was incorporated in 1897 and is headquartered in Franklin Lake, New Jersey.


DEAL STATS #
Overall 13 of 30
Sector: Software M&A 1 of 1
Type: Add-on Acquisition M&A Deals 13 of 25
Country: Austria M&A 1 of 1
Year: 2013 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-11-01 Discovery Labware

Billerica, Massachusetts, United States

Discovery Labware unit’s main product platforms: plastic consumable labware (including tubes, pipettes, Petri dishes, tissue culture dishes, and flasks); liquid-handling products; cell-based assays and cell cultureware; and ADME research.

Sell $720M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-01-07 Alverix

San Jose, California, United States

Alverix, Inc. is a key supplier to BD Diagnostics’ point-of-care instrument platform.

Buy $40M